Table 1 Preoperative patients characteristics.
Characteristics | n = 13 |
|---|---|
Age (years), median (IQR) | 71 (63–75) |
BMI (kg/m2), median (IQR) | 26.6 (22.5–28.7) |
CCI (age adjusted), median (IQR) | 6 (6–7) |
PSA at biopsy (ng/ml), median (IQR) | 6.8 (5.6–7.4) |
PSA density (MRI; ng/ml/ml), median (IQR) | 0.15 (0.11–0.26) |
Clinical stage (based on DRE), n (%) | |
cT1 | 5 (38.5) |
cT2 | 5 (38.5) |
cT3 | 3 (23) |
MRI, n (%) | |
PIRADS 3 | 4 (30.7) |
PIRADS 4 | 2 (15.4) |
PIRADS 5 | 7 (53.8) |
MRI stage, n (%) | |
Organ confined | 9 (69.2) |
ECE/SVI | 4 (30.8) |
Biopsy ISUP grade group, n (%) | |
3 | 1 (7.7) |
4 | 9 (69.2) |
5 | 3 (23.1) |
Risk of LNM according to the Briganti nomogram (median, IQR) | 30 (20–63) |
PSMA-PET, no. of positive patients, n (%) | |
Prostate | 13 (100) |
Obturator LN | 9 (69.2) |
External iliac | 5 (38.4) |
Internal iliac | 3 (23) |
Common iliac | 1 (7.7) |
Presacral | 3 (23) |
miN1-2/miM1a outside ePLND template | 4 (30) |
PSMA-PET PROMISE v.2 STADIATION | |
miN1 | 6 (46.2) |
miN2 | 6 (46.2) |
miM1a | 1 (7.7) |
Positive lymph nodes at PSMA-PET, Median (IQR) | 1 (1–7) |
